SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.660-2.4%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (4820)6/2/2015 2:06:02 AM
From: Nanotoday1 Recommendation

Recommended By
Rawnoc

   of 12871
 
Agreed, but the claim was the Dr. Seymour said they have never paid any of the labs they have worked with (and I specifically was referencing the educational institutions).

Dr. Seymour is on record saying they paid Dr. Harris and/or her lab.

Nothing wrong with this. Grants and outside work are how these labs stay open to do their own research work.

Thank you for the civil and well reasoned response.

BTW, you do know that KARD is owned and operated by an NNVBC officer, right?

Krishna Menon is NNVC's Chief Regulatory Officer and owner and COO of KARD Scientific.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News